Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study-Reference-Cited by-同舟云学术

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

Published:2011-03 Issue:3 Volume:22 Page:664-670
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Rieger M.,Österborg A.,Pettengell R.,White D.,Gill D.,Walewski J.,Kuhnt E.,Loeffler M.,Pfreundschuh M.,Ho A.D.

Funder

Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/3/664/719762/mdq418.pdf

Reference34 articles.

1. Primary mediastinal lymphoma in adults;Lichtenstein;Am J Med,1980

2. Primary mediastinal (thymic) large B-cell lymphoma;Gaulard,2008

3. Primary mediastinal B-cell lymphoma;Boleti;Hematol Oncol,2007

4. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma;Savage;Blood,2003

5. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma;Rosenwald;J Exp Med,2003

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Результаты терапии первичной медиастинальной В-крупноклеточной лимфомы. Опыт МРНЦ им. А.Ф. Цыба (Обнинск);Clinical Oncohematology;2024-07-01

2. Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study;Medicine;2024-02-23

3. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes;Journal of Clinical Oncology;2024-02-01

4. Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital;Clinical Lymphoma Myeloma and Leukemia;2024-01

5. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12